Clinical Trials Directory

Trials / Sponsors / Proacta, Incorporated

Proacta, Incorporated

Industry · 9 registered clinical trials.

StatusTrialPhaseStarted
TerminatedA Dose Escalation Trial of PR610 Treating Patients With Solid Tumors
Unspecified Adult Solid Tumor, Protocol Specific
Phase 1 / Phase 22012-08-01
UnknownPR104 in Treating Patients With Refractory/Relapsed Acute Leukemia
Acute Myelogenous Leukemia, Acute Lymphocytic Leukemia
Phase 1 / Phase 22010-01-01
TerminatedRandomized Phase 1/2 Open-Label Trial of PR104 and Sorafenib in Patients With Advanced Hepatocellular Carcinom
Hepatocellular Carcinoma
Phase 1 / Phase 22009-03-01
TerminatedRandomized, Multi-center, Open-label, Study of PR104 Versus PR104/Docetaxel in Non-Small Cell Lung Cancer (NSC
Non-Small Cell Lung Cancer
Phase 22009-03-01
CompletedPR104 and G-CSF in Treating Patients With Solid Tumors
Unspecified Adult Solid Tumor, Protocol Specific
Phase 12008-02-01
TerminatedPR104 in Treating Patients With Previously Untreated or Relapsed Small Cell Lung Cancer
Lung Cancer
Phase 22007-08-01
CompletedPR-104 and Docetaxel or Gemcitabine in Treating Patients With Solid Tumors
Unspecified Adult Solid Tumor, Protocol Specific
Phase 12007-02-01
CompletedA Phase I Dose Escalation Trial of PR104 Given Weekly in Subjects With Solid Tumors
Unspecified Adult Solid Tumor, Protocol Specific
Phase 12006-12-01
CompletedPR-104 in Treating Patients With Advanced Solid Tumors
Unspecified Adult Solid Tumor, Protocol Specific
Phase 12005-12-01